BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37857146)

  • 1. ATP ion channel P2X7 receptor as a regulatory molecule in the progression of colorectal cancer.
    Zuo C; Xu YS; He PF; Zhang WJ
    Eur J Med Chem; 2023 Dec; 261():115877. PubMed ID: 37857146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A438079 affects colorectal cancer cell proliferation, migration, apoptosis, and pyroptosis by inhibiting the P2X7 receptor.
    Zhang Y; Li F; Wang L; Lou Y
    Biochem Biophys Res Commun; 2021 Jun; 558():147-153. PubMed ID: 33915328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P2 purinergic receptors regulate the progression of colorectal cancer.
    Zhang WJ; Zhang LP; Lin SJ; Wang CY; Le YG
    Purinergic Signal; 2023 Dec; ():. PubMed ID: 38153612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ATP ion channel P2X purinergic receptors in inflammation response.
    Liu JP; Liu SC; Hu SQ; Lu JF; Wu CL; Hu DX; Zhang WJ
    Biomed Pharmacother; 2023 Feb; 158():114205. PubMed ID: 36916431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptor large pore signaling in avian Müller glial cells.
    Faria RX; Freitas HR; Reis RAM
    J Bioenerg Biomembr; 2017 Jun; 49(3):215-229. PubMed ID: 28573491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P2X7 receptor in inflammation and pain.
    Hu SQ; Hu JL; Zou FL; Liu JP; Luo HL; Hu DX; Wu LD; Zhang WJ
    Brain Res Bull; 2022 Sep; 187():199-209. PubMed ID: 35850190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in the relationship between P2X7R and colorectal cancer.
    Bai X; Li X; Qiao C; Tang Y; Zhao R; Peng X
    Mol Biol Rep; 2023 Feb; 50(2):1687-1699. PubMed ID: 36417079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of P2X7 receptor on tumorigenesis and its pharmacological properties.
    Zhang WJ; Hu CG; Zhu ZM; Luo HL
    Biomed Pharmacother; 2020 May; 125():109844. PubMed ID: 32004973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility study of B16 melanoma therapy using oxidized ATP to target purinergic receptor P2X7.
    Hattori F; Ohshima Y; Seki S; Tsukimoto M; Sato M; Takenouchi T; Suzuki A; Takai E; Kitani H; Harada H; Kojima S
    Eur J Pharmacol; 2012 Nov; 695(1-3):20-6. PubMed ID: 22981895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The P2X7 receptor modulates immune cells infiltration, ectonucleotidases expression and extracellular ATP levels in the tumor microenvironment.
    De Marchi E; Orioli E; Pegoraro A; Sangaletti S; Portararo P; Curti A; Colombo MP; Di Virgilio F; Adinolfi E
    Oncogene; 2019 May; 38(19):3636-3650. PubMed ID: 30655604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lidocaine preferentially inhibits the function of purinergic P2X7 receptors expressed in Xenopus oocytes.
    Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Minami T; Kawasaki T; Sata T
    Anesth Analg; 2015 Mar; 120(3):597-605. PubMed ID: 25695577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P2X7 receptor: a critical regulator and potential target for breast cancer.
    Zhu X; Li Q; Song W; Peng X; Zhao R
    J Mol Med (Berl); 2021 Mar; 99(3):349-358. PubMed ID: 33486566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
    Scarpellino G; Genova T; Munaron L
    Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. P2X7 receptors at adult neural progenitor cells of the mouse subventricular zone.
    Messemer N; Kunert C; Grohmann M; Sobottka H; Nieber K; Zimmermann H; Franke H; Nörenberg W; Straub I; Schaefer M; Riedel T; Illes P; Rubini P
    Neuropharmacology; 2013 Oct; 73():122-37. PubMed ID: 23727220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of P2X7 receptor and NLRP3 inflammasome assembly in hippocampal glial cells mediates chronic stress-induced depressive-like behaviors.
    Yue N; Huang H; Zhu X; Han Q; Wang Y; Li B; Liu Q; Wu G; Zhang Y; Yu J
    J Neuroinflammation; 2017 May; 14(1):102. PubMed ID: 28486969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antagonism of the ATP-gated P2X7 receptor: a potential therapeutic strategy for cancer.
    Drill M; Jones NC; Hunn M; O'Brien TJ; Monif M
    Purinergic Signal; 2021 Jun; 17(2):215-227. PubMed ID: 33728582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Coupling between the P2X
    Inoue H; Kuroda H; Ofusa W; Oyama S; Kimura M; Ichinohe T; Shibukawa Y
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34205953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ca(2+) spiking activity caused by the activation of store-operated Ca(2+) channels mediates TNF-α release from microglial cells under chronic purinergic stimulation.
    Ikeda M; Tsuno S; Sugiyama T; Hashimoto A; Yamoto K; Takeuchi K; Kishi H; Mizuguchi H; Kohsaka SI; Yoshioka T
    Biochim Biophys Acta; 2013 Dec; 1833(12):2573-2585. PubMed ID: 23830920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ATP-P2X7 Receptor Modulates Axon Initial Segment Composition and Function in Physiological Conditions and Brain Injury.
    Del Puerto A; Fronzaroli-Molinieres L; Perez-Alvarez MJ; Giraud P; Carlier E; Wandosell F; Debanne D; Garrido JJ
    Cereb Cortex; 2015 Aug; 25(8):2282-94. PubMed ID: 24610121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of purinergic receptors and NOD-like receptor-family protein 3-inflammasome pathway in the adenosine triphosphate-induced cytokine release from macrophages.
    Gicquel T; Victoni T; Fautrel A; Robert S; Gleonnec F; Guezingar M; Couillin I; Catros V; Boichot E; Lagente V
    Clin Exp Pharmacol Physiol; 2014 Apr; 41(4):279-86. PubMed ID: 24472059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.